JNJ dividend yield: 3.36%. AME dividend yield: 4.00%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. AME is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in AME shares.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
AME is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in AME shares.
JNJ currently offers a 3.36% yield (4.96/share/year) while AME offers 4.00% (2.00/share/year). AME provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs AME earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. AME pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $899/year (AME).
Does JNJ or AME pay monthly dividends?
JNJ pays quarterly dividends. AME pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs AME comparison by email
Save your analysis + get weekly dividend insights. Free forever.